EP2213285
Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.12.2004EP published:
6.11.2013EP application number:
09177200.4
EPO information:
European Patent Register
Max expiry date:
16.12.2024
Title:
Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
Timeline
Today
17.12.2004EP application
6.11.2013EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Brinkmann, VolkerAddress:
Freiburg, DE
Name:
Kaneider, NicoleAddress:
Innsbruck, AT
Name:
Wiedermann, Christian J.Address:
Innsbruck, AT
Priority
Number:
0329498Date:
19.12.2003Country:
GB
Classification
Categories:
A61K 31/133, A61K 31/135, A61K 31/00, A61K 45/06, A61K 31/661, A61P 25/28